StemMedical A/S: Financial statements 2020
CVR: 35852808
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
StemMedical A/S (CVR 35852808) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,792,953 and a net result of DKK -7,736,566 compared with DKK -4,083,120 the year before. Equity in the 2020 report amounted to DKK 29,606,487. The solvency ratio was 95%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -3,792,953
- Profit/Loss
- DKK -7,736,566
- Equity
- DKK 29,606,487
- Total Assets
- DKK 31,148,660
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -3.8M | -7.7M | 29.6M | 5 |
| 2019 | - | -2.1M | -4.1M | 5.5M | 4 |
| 2018 | - | -1.5M | -2.4M | 6.3M | 3 |
| 2017 | - | -1.7M | -1.9M | 5.4M | - |
| 2016 | - | -716K | -2.3M | 6.8M | - |
Official annual report
How creditworthy is StemMedical A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
StemMedical A/S has published its annual report for 2019. Gross profit came to DKK -2,061,686, and the net result was DKK -4,083,120.
As of May 5, 2020, Stig Løkke Pedersen is registered as chairman of StemMedical A/S.
As of May 5, 2020, Christian Nissen Riisberg is registered as vice chairman of StemMedical A/S.
As of May 4, 2020, Christian Nissen Riisberg has stepped down as chairman of StemMedical A/S.
About StemMedical A/S
StemMedical A/S was a Danish company of the type Aktieselskab based in Søborg, founded in 2014. The company has been dissolved on 25 September 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named STEMFORM A/S and STEMFORM ApS. The company has 18 employees (2024). In 2022, the company reported a gross profit of DKK -7,902,529 and a net result of DKK -18,876,055 compared with DKK -13,221,367 the year before. Equity in the 2022 report amounted to DKK 12,392,865.